[1] 张一秋, 石洪成, 顾宇参, 等. SPECT/CT骨显像对肺癌骨转移诊断的增益价值[J].中华核医学杂志, 2011, 31(4):219-222. DOI:10.3760/cma.j.issn.0253-9780.2011.04.002.
Zhang YQ, Shi HC, Gu YS, et al. The added diagnostic value of SPECT/CT imaging for bone metastases from lung cancer[J]. Chin J Nucl Med, 2011, 31(4):219-222.  doi: 10.3760/cma.j.issn.0253-9780.2011.04.002
[2] 王新华, 赵艳萍, 陆海健, 等. SPECT/CT显像诊断转移性骨肿瘤的临床意义[J].中华核医学杂志, 2010, 30(2):106-109. DOI:10.3760/cma.j.issn.0253-9780.2010.02.010.
Wang XH, Zhao YP, Lu HJ, et al. Clinical value of SPECT/CT imaging in the diagnosis of bone metastasis[J]. Chin J Nucl Med, 2010, 30(2):106-109.  doi: 10.3760/cma.j.issn.0253-9780.2010.02.010
[3] 董科, 石洪成, 刘江, 等. SPECT/CT显像在肿瘤骨转移同一病灶动态随访中的价值[J].中华核医学与分子影像杂志, 2013, 33(3):199-202. DOI:10.3760/cma.j.issn.2095-2848.2013.03.011.
Dong K, Shi HC, Liu J, et al. Value of SPECT/CT imaging for follow-up of bone metastases[J]. Chin J Nucl Med Mol Imaging, 2013, 33(3):199-202.  doi: 10.3760/cma.j.issn.2095-2848.2013.03.011
[4]

赫捷, 赵平, 陈万青.中国肿瘤登记年报[M].北京:军事医学科学出版社, 2012.

He J, Zhao P, Chen WQ. China's annual report on tumor registration[M]. Beijing:Military Medical Science Press, 2012.

[5] 桂文来, 刘增礼, 杨仪, 等. 256例肺癌骨转移核素骨显像的特点分析[J].苏州大学学报(医学版), 2005, 25(3):476, 487. DOI:10.3969/j.issn.1673-0399.2005.03.041.
Gui WL, Liu ZL, Yang Y, et al. Analysis of characteristics of radionuclide bone imaging in 256 cases of lung cancer with bone metastases[J]. Suzhou Univ J Med Sci, 2005, 25(3):476, 487. DOI:10.3969/j.issn.1673-0399.2005.03.041.
[6] 郭庆志, 吴梅娜, 安彤同, 等. 322例非小细胞肺癌骨转移临床特点及治疗的回顾性分析[J].中国肺癌杂志, 2014, 17(9):656-662. DOI:10.3779/j.issn.1009-3419.2014.09.03.
Guo QZ, Wu MN, An TT, et al. Characteristics and treatment of bone metastases in 322 cases non-small cell lung cancer:a retrospective study[J]. Chin J Lung Cancer, 2014, 17(9):656-662.  doi: 10.3779/j.issn.1009-3419.2014.09.03
[7] 梁树君, 赵斌, 周绍军, 等.肺腺癌或鳞状细胞癌患者SPECT/CT全身骨显像诊断骨转移的影像特点及临床价值[J].国际肿瘤学杂志, 2015, 42(6):407-409. DOI:10.3760/cma.j.issn.1673-422X.2015.06.002.
Liang SJ, Zhao B, Zhou SJ, et al. Characteristics and clinical values of SPECT/CT whole-body bone scanning in detecting bone metastases in patients with lung adenocarcinoma or squamous cell carcinoma[J]. J Int Oncol, 2015, 42(6):407-409.  doi: 10.3760/cma.j.issn.1673-422X.2015.06.002
[8] 宋霞, 陈涛, 王一萍, 等. TSGF、AFP、CEA、CA199、CA50联合检测对消化道恶性肿瘤早期诊断价值[J].国际检验医学杂志, 2015, 36(1):118-120. DOI:10.3969/j.issn.16734130.2015.01.053.
Song X, Chen T, Wang YP, et al. Combined detection of TSGF, AFP, CEA, CA199 and CA50 for early diagnosis of gastrointestinal cancer[J]. Int J Lab Med, 2015, 36(1):118-120.  doi: 10.3969/j.issn.16734130.2015.01.053
[9] Duffy MJ, van Dalen A, Haglund C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use[J]. Eur J Cancer, 2007, 43(9):1348-1360. DOI:10.1016/j.ejca.2007.03.021.
[10] 范光磊, 万仁明, 彭鸣亚, 等.癌胚抗原、糖类抗原15-3及骨转换生化标志物检测对乳腺癌骨转移的诊断意义[J].中华核医学与分子影像杂志, 2013, 33(3):203-206. DOI:10.3760/cma.j.issn.2095-2848.2013.03.012.
Fan GL, Wan RM, Peng MY, et al. Significance of CEA, CA15-3 and biochemical markers of bone turnover in the diagnosis of bone metastasis from breast cancer[J]. Chin J Nucl Med Mol Imaging, 2013, 33(3):203-206.  doi: 10.3760/cma.j.issn.2095-2848.2013.03.012
[11] 洪军, 孙爱军.血清CEA、CA125、CYFRA21-1、NSE联合检测在肺癌诊断中的应用价值[J].河北医药, 2014, 36(5):697-699. DOI:10.3969/j.issn.1002-7386.2014.05.022.
Hong J, Sun AJ. Combined detection of serum CEA, CA125, CYFRA21-1 and NSE in the diagnosis of lung cancer[J]. Hebei Med J, 2014, 36(5):697-699.  doi: 10.3969/j.issn.1002-7386.2014.05.022
[12] Szturmowicz M, Rudziński P, Kacprzak A, et al. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer[J]. Pneumonol Alergol Pol, 2014, 82(5):422-429. DOI:10.5603/PiAP.2014.0055.
[13] 赵义刚, 勾正兴. 99Tcm-MDP全身骨显像诊断肺癌骨转移的临床价值[J].标记免疫分析与临床, 2016, 23(6):645-647. DOI:10.11748/bjmy.issn.1006-1703.2016.06.014.
Zhao YG, Gou ZX. The clinical value of 99Tcm-MDP whole body bone imaging in diagnosing bone metastasis of lung cancer[J]. Labeled Immunoassays & Clin Med, 2016, 23(6):645-647.  doi: 10.11748/bjmy.issn.1006-1703.2016.06.014
[14] 沈维敏, 许佳毅, 唐曦. ECT联合肿瘤标志物检测诊断老年肺癌骨转移的临床观察[J].首都医药, 2014, 20:28-29. DOI:10.3969/j.issn.1005-8257.2014.20.016.
Shen WM, Xu JY, Tang X. Evaluation of tumor marker and ECT in diagnosis of bone metastasis in elder lung cancers[J]. Capit Med, 2014, 20:28-29. DOI:10.3969/j.issn.1005-8257.2014.20.016.
[15] 凌彩霞, 肖国有. SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志, 2014, 38(4):275-277. DOI:10.3760/cma.j.issn.1673-4114.2014.04.016.
Ling CX, Xiao GY. The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J]. Int Radiat Med Nucl Med, 2014, 38(4):275-277.  doi: 10.3760/cma.j.issn.1673-4114.2014.04.016
[16] 张雪辉, 孔飚, 肖国有, 等. SPECT/CT显像对脊柱良恶性病变诊断的增益价值[J].中华核医学与分子影像杂志, 2016, 36(2):156-160. DOI:10.3760/cma.j.issn.2095-2848.2016.02.013.
Zhang XH, Kong B, Xiao GY, et al. The added value of SPECT/CT imaging for diagnosing benign and malignant lesions of spine[J]. Chin J Nucl Med Mol Imaging, 2016, 36(2):156-160.  doi: 10.3760/cma.j.issn.2095-2848.2016.02.013
[17] 林琳, 刘琳, 贾莹莹, 等. SPECT/CT对骨显像疑难病灶的诊断增益分析[J].中国医学影像技术, 2014, 30(4):560-563. DOI:10.13929/j.1003-3289.2014.04.017.
Lin L, Liu L, Jia YY, et al. The added diagnostic value of SPECT/CT imaging for difficult lesions[J]. Chin J Med Imaging Technol, 2014, 30(4):560-563.  doi: 10.13929/j.1003-3289.2014.04.017